Microfluidic Device for Human Bone Marrow Niche Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current models fail to accurately recreate the biological and functional complexity of the human bone marrow niche, which is essential for understanding hematopoietic stem/progenitor cell interactions and malignant cell behavior, due to challenges in visualizing and modeling the complex niche environment in humans.
Innovation Solution
An in vitro microfluidic device with multiple chambers containing specific populations of cells such as mesenchymal cells, osteoblasts, arterial endothelium, and sinusoidal endothelium, housed in a hydrogel carrier, allowing for fluid flow and real-time imaging of cell interactions, enabling the recreation of a hematopoietic microenvironment that mimics the human bone marrow niche.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If in vivo murine models are used to study HSPC-niche interactions, then ease of genetic manipulation and in vivo imaging capability are improved, but species-specific differences from human bone marrow reduce the translational relevance to human hematopoiesis
Solution Approach 1:
The patent creates in vitro human bone marrow niche models that copy and replicate human HSPC-niche interactions ex vivo, eliminating the need for murine systems while maintaining human-specific biological relevance. The microfluidic devices reconstruct human bone marrow microenvironments with human stromal cells, endothelial cells, and HSPCs, allowing direct study of human hematopoiesis without species translation issues.
2Reliability
If complex human bone marrow niche environments are modeled in vitro, then translational relevance to human hematopoiesis is improved, but difficulty in visualizing and modeling the complex niche environment increases
Solution Approach 1:
The patent segments the complex bone marrow niche into distinct functional compartments within microfluidic devices, including osteoblastic niches, endothelial niches, and stromal niches. Each compartment can be independently configured with specific cell types and ECM compositions, making the complex environment manageable while preserving overall biological fidelity.
Solution Approach 2:
The patent transitions from two-dimensional culture systems to three-dimensional microfluidic devices that replicate the spatial architecture of bone marrow niches. The devices incorporate 3D extracellular matrix scaffolds and enable volumetric imaging, allowing visualization of HSPC-niche interactions in three dimensions rather than flat monolayers.
3Reliability
If multiple cell populations are cultured together to recreate bone marrow niche complexity, then biological and functional complexity of the niche is improved, but isolation and characterization of specific cell-cell interactions becomes more difficult
Solution Approach 1:
The patent uses spatial segmentation within microfluidic devices to separate different cell populations into distinct niches while maintaining controlled interactions. Each niche compartment contains specific stromal cell types (osteoblasts, endothelial cells, mesenchymal stromal cells) that can interact with HSPCs in a controlled manner, allowing researchers to study specific cell-cell interactions by activating or deactivating individual compartments.
Solution Approach 2:
The patent introduces microfluidic channels and extracellular matrix scaffolds as intermediaries that mediate controlled interactions between cell populations. These intermediaries allow selective diffusion of signaling molecules while physically separating cell types, enabling researchers to study paracrine signaling and cell-cell contact interactions in a controlled manner.
Data Source
AI summary
Provided herein according to some embodiments is an in vitro construct useful as a model for a hematopoietic microenvironment, which may include: a microfluidic device having multiple chambers; and two or more populations of cells (e.g., 3 or 4 populations of cells) (or“niches”) selected from: 1) mesenchymal cells (e.g., Stro-1+; MSC); 2) osteoblasts (OB; optionally said osteoblasts provided by differentiating mesenchymal cells to differentiated osteoblasts); 3) arterial endothelium (e.g., CD146+NG2+; AEC); and 4) sinusoidal endothelium (CD146+NG2−; SEC), wherein each of said two or more populations of cells are provided in a separate chamber of the microfluidic device. Methods of making and using the construct are also provided.